Fortis Healthcare News
Delhi’s Indraprastha Apollo hospital and Fortis Healthcare begins administering the Sputnik V vaccine.
"On-the-spot registration and walk-in facility for Sputnik V is currently restricted, we are encouraging beneficiaries to take appointments through the CoWin app," the official said.
According to the filing to the BSE, Yes Bank sold 1,51,06,283 equity shares of the company, constituting 2.0010 per cent of the paid-up share capital of Fortis Healthcare Ltd as on March 31, 2019, in various tranches, last being on June 7, 2019.
Fortis in August 2018 had applied for reclassification of these promoters. Post reclassification, Northern TK Venture Pte Ltd remains the promoter of the firm with a 31.17 percent stake in the healthcare firm.
Consolidated revenue from operations increased to Rs 1,184.15 crore from Rs 1,086.38 crore in the same quarter a year ago, Fortis Healthcare said in a filing to BSE.
Pointing to the reason for the delay in the open offer, IHH Healthcare said it was on account of the stay imposed on it by the Supreme Court in the contempt case filed by Daiichi Sankyo.
Mauritius-based Fortis Healthcare International holds 28.89 percent stake in MSCL.
Singh brothers, erstwhile promoters of FHL, have also been asked not to associate themselves with the affairs of FHL and FHsL in any manner.
Fortis Healthcare has also asked the Securities and Exchange Board of India (Sebi) for a personal hearing on the matter.
It has also extended the last date for the acquisition of portfolio of assets of the Singapore-listed entity RHT Health Trust to March 26, 2019.
Companies are required to inform the exchanges if the change in shareholding of an entity is over 2 percent.
The open offer for an additional 26 percent stake was scheduled to commence on December 18 and close on January 1, 2019 entailing a total sum of Rs 3,300 crore.
The allotment has been done at Rs 170 per share.
Singh has steered the organisation over the past three and a half years.
The binding offer is valid till July 16, 2018, IHH Healthcare Berhad said in a regulatory filing.
In May, Fortis Healthcare had initiated a fresh time- bound bidding process for its sale after terminating the offer made by the Munjal-Burman combine.
The company had posted a net loss of Rs 37.52 crore for the corresponding period of the previous fiscal, Fortis Healthcare said in a BSE filing.
Last month, Fortis Healthcare had initiated a fresh time-bound bidding process for its sale after terminating the offer made by the Munjal-Burman combine.
The development comes at a time when there is an uncertainty over the process of sale of Fortis as four of the directors, who had approved the Munjals-Burmans bid, are no longer on the company's board.
This week, the shareholders had voted out the fourth director, Brian Tempest, from the board in the extraordinary general meeting (EGM) held on May 22.
Three directors - Harpal Singh, Sabina Vaisoha and Tejinder Singh Shergill- had already resigned before the EGM.
Loading...